<p class="reg-lead">Part 13 of the Union Cycliste Internationale (UCI) Regulations — Medical Rules, in force from 10 February 2026.</p>
<table class="reg-facts">
<tr><td>In force</td><td><b>10 February 2026</b></td></tr>
<tr><td>Structure</td><td>Part 13 of the UCI Regulations — five chapters and an annex of medical guidelines</td></tr>
<tr><td>Status</td><td><strong>Current edition</strong></td></tr>
</table>
<div class="reg-sec">
<h2>What Part 13 governs</h2>
<p>The Regulations of the Union Cycliste Internationale (UCI) are divided into <strong>seventeen numbered parts</strong>, which sit alongside the Constitution and the Code of Ethics. Each article carries its own three-part number — such as 13.3.066 — whose first figure is the number of that part. This document is <strong>Part 13</strong> of that body of regulations.</p><p>The Medical Rules cover everything from the Olympic Movement Medical Code to the role of each medical actor in cycling, health monitoring of riders, medical services at events, and the eligibility conditions for transgender athletes.</p>
</div>
<div class="reg-sec hi">
<h2>Key points</h2>
<ol class="reg-tl">
<li><b class="t">Ban on carbon monoxide inhalation outside medical facilities</b>Article <strong>13.3.066</strong> — one of the newest provisions of this edition: the use of systems or equipment that enable the <strong>inhalation of carbon monoxide</strong> is prohibited both in competition and out of it. This method falls under category <strong>M1.4 of the Prohibited Methods</strong> in the Prohibited List.</li>
<li><b class="t">Concussion diagnosis and return to competition</b>Section 5 of Chapter 3 specifically governs the diagnosis of concussion and the conditions for returning to competition afterwards.</li>
<li><b class="t">Ban on injections</b>Section 4 of Chapter 3 lays down the <strong>ban on injections</strong> — one of the oldest and best-known medical rules in cycling.</li>
<li><b class="t">Medical monitoring of professional teams and women's disciplines</b>Sections 2 and 3 establish the medical monitoring regime separately for WorldTeams and ProTeams, and for the women's disciplines in road, mountain bike (cross-country), track and BMX.</li>
<li><b class="t">Medical actors</b>Chapter 2 separates the roles: the UCI Medical Commission, the UCI Doctor, the UCI Medical Delegate, national doctors, team doctors and paramedical assistants — each with its own powers and responsibilities.</li>
<li><b class="t">Eligibility of transgender athletes</b>Chapter 5 contains a self-standing set of regulations on the eligibility of transgender athletes, in twelve sections: scope of application, eligibility conditions, case-by-case assessment, investigation and monitoring of continued compliance, <strong>disciplinary proceedings</strong>, dispute resolution, confidentiality, costs, mutual recognition, limitation of liability and transitional provisions.</li>
<li><b class="t">Olympic Movement Medical Code</b>Chapter 1 incorporates the Olympic Movement Medical Code into the text of the UCI Regulations, meaning that a breach of the Code is also a breach of the UCI Regulations.</li>
</ol>
</div>
<div class="reg-sec">
<h2>Who this document matters to</h2>
<p>For team doctors, this document defines the limits of their professional authority and duties within the sporting framework, and a breach carries disciplinary consequences. The carbon monoxide ban is a new and significant point: because it has been placed on the list of prohibited methods, a breach falls simultaneously under the Medical Rules and the anti-doping regulations. The chapter on transgender athletes likewise has its own procedural route for proceedings and dispute resolution.</p>
</div>

UCI Cycling Regulations Part 13 — Medical Rules 2026

<p class="reg-lead">The current version is the edition of 23 June 2023; the definition of anti-doping rule violations and the rules for establishing them were set out in greater detail, and a reporting duty concerning athlete support personnel was brought into the text.</p>
<table class="reg-facts">
<tr><td>In force from</td><td><b>23 June 2023</b></td></tr>
<tr><td>Issued by</td><td>Fédération Internationale de Volleyball — 2023 edition</td></tr>
<tr><td>Structure</td><td>Medical section + anti-doping rules and definitions annex</td></tr>
<tr><td>Status</td><td><strong>Current version</strong> — the governing medical and anti-doping regulations</td></tr>
</table>
<div class="reg-sec">
<h2>What are the FIVB Medical and Anti-Doping Regulations?</h2>
<p>The Medical and Anti-Doping Regulations of the Fédération Internationale de Volleyball (FIVB) bring together two instruments in a single text: the medical rules for events — including the injury reporting procedure — and the <strong>Anti-Doping Rules</strong>, which implement the World Anti-Doping Code in volleyball. The federation may delegate part or all of doping control to a third party such as the <strong>International Testing Agency (ITA)</strong>, and adjudication and results management to the <strong>Anti-Doping Division of the Court of Arbitration for Sport</strong>, but responsibility for compliance remains its own.</p>
</div>
<div class="reg-sec hi">
<h2>About the June 2023 edition<span class="reg-tag">Changes from January 2021</span></h2>
<h3>Key changes from the previous edition</h3>
<ol class="reg-tl">
<li><b class="t">Anti-doping rule violations set out in detail, and strict liability</b>The article on violations was rewritten so as to determine more precisely the circumstances and conduct that constitute a violation, with renewed express provision that <strong>proof of intent, fault, negligence or knowing use is not required</strong>.</li>
<li><b class="t">Rules for establishing use</b>It was made clear that <strong>use or attempted use alone</strong> of a prohibited substance or method suffices to constitute a violation, and that use may be established on the basis of <strong>reliable analytical data from the A sample, without confirmation by the B sample</strong>. The organisation responsible for results management may also, at its own discretion, analyse the <strong>B sample even without a request from the athlete</strong>.</li>
<li><b class="t">Distinction between sample-collection violations</b>The difference between <strong>"failing to submit to sample collection"</strong> — which may be intentional or negligent — and <strong>"evading" and "refusing"</strong> was clarified.</li>
<li><b class="t">Complicity and athlete support personnel</b>It was expressly provided that <strong>complicity or attempted complicity includes physical and psychological assistance</strong>, and anti-doping organisations were placed under a duty to <strong>report</strong> athlete support personnel who meet the prescribed criteria.</li>
</ol>
</div>
<div class="reg-sec">
<h2>Who this document matters to</h2>
<p>Every doping case involving Iranian volleyball players is adjudicated on the basis of this text. The decisive point in a defence: liability is <strong>strict</strong>, and establishing a violation requires no proof of intent, fault or negligence on the athlete's part. The medical regulations likewise impose obligations on the team doctor and the federation at international events.</p>
</div>

Notes related to the tag مقررات_پزشکی

UCI Cycling Regulations Part 13 — Medical Rules 2026

FIVB Medical and Anti-Doping Regulations 2023